Skip to content
MomMetabolicEVIDENCE-FIRST METABOLIC HEALTH
Menu

Evidence review

GLP-1s and Birth Control: Does Zepbound or Ozempic Affect the Pill?

Tirzepatide carries a real FDA warning that the pill can work less well; injectable semaglutide does not. What that means if you rely on oral birth control.

Written by Elena Voss, Metabolic Health Editor

Elena Voss is a mother writing for mothers, not a treating clinician. The evidence in this piece was checked against its primary sources by Grant Okonkwo, a former pharmaceutical-industry analystElena and Grant hold no medical license, and this is background reading, not medical advice.

On this page

The short version

If you take the pill, this is not a footnote. Tirzepatide — sold as Zepbound for weight loss and Mounjaro for diabetes — carries an explicit FDA warning that oral hormonal contraceptives may become less effective, and the label advises switching to a non-oral method or adding a barrier method for four weeks after you start and for four weeks after each dose increase1. Injectable semaglutide (Wegovy, Ozempic) does not carry that warning, and a dedicated study found it did not reduce the absorption of a combined oral contraceptive3. So the honest headline is molecule-specific: on tirzepatide, assume the pill needs backup around starting and every dose bump; on injectable semaglutide, the pill is not expected to be undermined. For a mother who is not planning a pregnancy right now, getting this right is exactly as important as the weight loss itself.

This is educational only, not medical advice — but it's a genuine drug difference that a lot of weight-loss coverage skips.

Why tirzepatide can blunt the pill

The mechanism is the same one behind the nausea and fullness: these drugs slow how fast the stomach empties, and that slowing is most pronounced right after the first dose and after each dose increase. A pill you swallow has to be absorbed from the gut on a fairly predictable schedule; when gastric emptying is delayed and variable, the amount of hormone that actually gets absorbed can drop. A pharmacokinetic review of GLP-1 and dual GIP/GLP-1 medications describes exactly this — delayed gastric emptying altering the absorption of co-administered oral drugs, including oral contraceptives, following tirzepatide2. It's strongest early and after escalation, which is precisely the window the FDA label tells you to cover with a backup method1.

Why injectable semaglutide is different

You'd expect semaglutide to do the same thing — it also slows gastric emptying — but the contraception data don't bear that out. In a dedicated study, women took a combined ethinylestradiol/levonorgestrel pill before and during semaglutide treatment, and semaglutide did not reduce the bioavailability of either hormone3. That's why the Wegovy label doesn't carry tirzepatide's oral-contraceptive warning4. The practical read: on injectable semaglutide, your oral birth control is not expected to be weakened. (A caution worth naming: if severe vomiting or diarrhea is causing you to lose a pill dose, that can reduce effectiveness with any medication — a general sick-day rule, not a semaglutide-specific interaction.)

One more nuance mothers ask about: this warning is about the drug's effect on absorption. If you're on tirzepatide and having significant GI side effects, that's a double reason to have a backup method — both the slowed absorption and any vomiting can matter. Our guide to managing GLP-1 side effects covers the GI piece.

What this means in practice

  • On tirzepatide (Zepbound/Mounjaro) and relying on the pill? Talk to your clinician about a non-oral method — an IUD, implant, injection, patch, or ring — or add a barrier method (like condoms) for four weeks after starting and four weeks after every dose increase1. Non-oral methods sidestep the gut-absorption problem entirely.
  • On injectable semaglutide (Wegovy/Ozempic)? Your oral contraceptive is not expected to be affected34, though the general sick-day rule about lost doses from vomiting or diarrhea still applies.
  • Not sure which situation is yours? Bring the exact product name to the conversation. The molecule, not the marketing category, decides this.

The bigger reason contraception belongs in this conversation

There's a second, non-negotiable reason to get birth control right on a GLP-1: these drugs are not used in pregnancy. The semaglutide label advises stopping well before a planned pregnancy because the drug persists for roughly a week per dose4, and the same timing logic applies to tirzepatide. An unplanned pregnancy on a GLP-1 is precisely what effective contraception exists to prevent — so "is my birth control still working" isn't only about avoiding pregnancy in general, it's about avoiding a pregnancy while on a medication you'd need to stop. If conceiving is the goal, that's a planned washout, not a surprise — and if you have PCOS, note that weight loss can restore ovulation and fertility that felt unreliable before, which our PCOS evidence guide discusses.

How to choose a provider that handles this well

This is a small question with a big consequence, and it's a fast test of whether a program is actually practicing medicine. A provider that asks what contraception you use before prescribing tirzepatide — and adjusts the plan around dose increases — is doing the job; one that never raises it is a red flag. That kind of reproductive-aware oversight is part of what our Metabolic-Fit Score methodology rewards, and why clinician-led options such as CoreAge Rx rank near the top of our best GLP-1 for women; some links here earn us a referral fee. For how the two molecules compare more broadly, see Zepbound vs Wegovy for a mother and our guide to GLP-1s, your cycle, and reproductive hormones. This article is educational only and not medical advice; take contraception decisions to a clinician who knows your history.

Frequently asked questions

Does Zepbound or Mounjaro make birth control pills less effective?

It can. Tirzepatide (Zepbound/Mounjaro) carries an FDA warning that oral hormonal contraceptives may become less effective because the drug slows stomach emptying and can reduce how much hormone is absorbed. The label advises switching to a non-oral method or adding a barrier method for four weeks after you start and for four weeks after each dose increase. A non-oral method like an IUD, implant, patch, or ring avoids the problem entirely.

Does Ozempic or Wegovy affect the pill the same way?

No. Injectable semaglutide (Wegovy, Ozempic) does not carry that warning, and a dedicated study found it did not reduce the absorption of a combined oral contraceptive. So on injectable semaglutide, your oral birth control is not expected to be weakened. The one general caveat is that severe vomiting or diarrhea that makes you lose a pill dose can reduce effectiveness with any medication.

Why does contraception matter so much on a GLP-1 anyway?

Because these drugs aren't used in pregnancy. The label advises stopping well before a planned pregnancy since the drug lingers about a week per dose. So reliable birth control isn't only about avoiding pregnancy in general — it's about avoiding a pregnancy while on a medication you'd have to stop. If conceiving is the goal, that's a planned washout with your clinician, not a surprise.

References

  1. U.S. Food and Drug Administration (2024). Zepbound (tirzepatide) injection — Prescribing Information (Drug Interactions: Oral Hormonal Contraceptives). DailyMed / FDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
  2. Min JS, Kim JK, Yoo H, et al. (2025). A Comprehensive Review on the Pharmacokinetics and Drug-Drug Interactions of Approved GLP-1 Receptor Agonists and a Dual GLP-1/GIP Receptor Agonist. Drug Design, Development and Therapy. https://pubmed.ncbi.nlm.nih.gov/40330819/
  3. Kapitza C, Nosek L, Jensen L, et al. (2015). Semaglutide, a once-weekly human GLP-1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel. Journal of Clinical Pharmacology. https://pubmed.ncbi.nlm.nih.gov/25475122/
  4. U.S. Food and Drug Administration (2024). Wegovy (semaglutide) injection — Prescribing Information (Drug Interactions; Use in Specific Populations: Pregnancy). DailyMed / FDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b

Background reading, not medical advice. MomMetabolic summarizes published research and FDA labeling for mothers weighing GLP-1 care. It cannot diagnose you, cannot account for your history or hormones, and is no substitute for a licensed clinician who can. Decisions to begin, adjust, pause, or stop any medication belong with your own prescriber.